Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection
NCT04834908
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
7
Enrollment
INDUSTRY
Sponsor class
Stopped
Closed as no eligible patient.
Conditions
SARS-CoV-2 Infection
Interventions
BIOLOGICAL:
Equine COVID-19 Antiserum
DRUG:
Standard of care
Sponsor
Bharat Serums and Vaccines Limited